Smith Jw
Indiana University Bloomington
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Smith Jw.
Antimicrobial Agents and Chemotherapy | 1991
M S Bartlett; Sherry F. Queener; R R Tidwell; W K Milhous; J D Berman; W Y Ellis; Smith Jw
Three 8-aminoquinolines from the Walter Reed Army Institute for Research (WRAIR), WR6026, WR238605, and WR242511, strongly inhibited Pneumocystis carinii growth in vitro at 1 microgram/ml. This activity was similar to that of primaquine. In rat therapy models, the WRAIR compounds affected Pneumocystis pneumonia at doses as low as 0.25 mg/kg (WR242511) or 0.5 mg/kg (WR6026 and WR238605). At these doses, primaquine alone was ineffective as therapy. In a rat prophylaxis model, all three WRAIR 8-aminoquinolines were extremely effective at daily doses of 0.57 mg/kg, showing activity greater than that of primaquine at this dosage and comparable to that of trimethoprim-sulfamethoxazole at 50/250 mg/kg.
Antimicrobial Agents and Chemotherapy | 1992
M S Bartlett; T D Edlind; M M Durkin; Margaret M. Shaw; Sherry F. Queener; Smith Jw
Nine antimicrotubule benzimidazole derivatives tested in a Pneumocystis carinii culture system with human embryonic lung fibroblast monolayers inhibited organism proliferation. The concentrations of drugs inhibitory in culture ranged from 10 to 0.1 micrograms/ml, with thiabendazole being the least effective (10 micrograms/ml) and parbendazole being the most effective (0.1 microgram/ml). The parent compound, benzimidazole, was inactive at 10 micrograms/ml. Demonstration that this group of compounds has activity against P. carinii provides a new potential target that can be exploited, the microtubules. Also, the variability in the effectiveness of the compounds provides the basis for studies of structure-activity relationships, which were initiated in this study.
Antimicrobial Agents and Chemotherapy | 1986
Marilyn S. Bartlett; J J Marr; Sherry F. Queener; Robert S. Klein; Smith Jw
Three analogs of inosine, formycin B, allopurinol ribonucleoside, and 9-deazainosine, were tested for their ability to suppress proliferation of Pneumocystis carinii in culture with WI-38 cells. The organism was inhibited by 9-deazainosine at 10 micrograms/ml, and there was some inhibition at 1 microgram/ml. Formycin B was effective only at 40 micrograms/ml. Allopurinol ribonucleoside had little effect.
Journal of Clinical Microbiology | 1998
Chao Hung Lee; Jannik Helweg-Larsen; Xing Tang; Shaoling Jin; Baozheng Li; Marilyn S. Bartlett; Jang Jih Lu; Bettina Lundgren; Jens D. Lundgren; Mats Olsson; Sebastian Lucas; Patricia Roux; Antonietta Cargnel; Chiara Atzori; Olga Matos; Smith Jw
Journal of Clinical Microbiology | 1997
Marilyn S. Bartlett; Sten H. Vermund; Robert Jacobs; Pamela J. Durant; Margaret M. Shaw; Smith Jw; Xing Tang; Jang Jih Lu; Baozheng Li; Shaoling Jin; Chao Hung Lee
Antimicrobial Agents and Chemotherapy | 1996
Marilyn S. Bartlett; William L. Current; Michael P. Goheen; Carole J. Boylan; Chao H. Lee; Margaret M. Shaw; Sherry F. Queener; Smith Jw
Journal of Clinical Microbiology | 1998
Xing Tang; Marilyn S. Bartlett; Smith Jw; Jang Jih Lu; Chao Hung Lee
Journal of Clinical Microbiology | 1996
Bingdong Jiang; Jang Jih Lu; Baozheng Li; Xing Tang; Marilyn S. Bartlett; Smith Jw; Chao Hung Lee
Journal of Clinical Microbiology | 1987
Marilyn S. Bartlett; Sherry F. Queener; M A Jay; Michelle Durkin; Smith Jw
Journal of Eukaryotic Microbiology | 1991
Michelle Durkin; Shaw Mm; Bartlett Ms; Smith Jw